Status: Not yet recruiting
Study of Remimazolam for Cataract Surgery
The goal of this clinical trial is to learn if the use of the sedative remimazolam improves the safety of patients having cataract surgery by decreasing the number of sedation-related complications during and after surgery, and shortening post-surgical cognitive recovery time.
Participants needed: 30
Trial details
Phase: Phase 4Age: 55-90Biological sex: AllType: InterventionalSponsor: Fred E, ShapiroUpdated: Apr 29, 2026Locations: 1
Eligibility criteria
Subject is planning to have cataract surgery in both eyes [+5]
Subject has a history of difficulty with sedation during procedures [+5]